T 1489/18 (Anti-NKG2A antibodies/INNATE) of 22.03.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T148918.20210322
- Date of decision
- 22 March 2021
- Case number
- T 1489/18
- Petition for review of
- -
- Application number
- 11185913.8
- IPC class
- C07K 16/28A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Monoclonal antibodies against NKG2A
- Applicant name
- Innate Pharma
Universita di Genova - Opponent name
- Merck Sharp & Dohme Corp.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.